Sign in

NCT03527719Active, not recruiting

China Rural Hypertension Control Project

Effectiveness of a Standardized Protocol-based Treatment Program on Hypertension Control in Rural China

Source: ClinicalTrials.gov · Last updated 18 Dec 2025

Brief summary (registry, in English)

China Rural Hypertension Control (CRHC) Project is a cluster randomized trial that will test the effectiveness of a village doctor-led multifaceted intensive blood pressure intervention on hypertension control in 18 months (Phase 1), cardiovascular disease risk in 36 months (Phase 2), and all-cause dementia in 48 months (Phase 3) among patients with hypertension in rural China. An extended observational follow-up, the CRHCP post-intervention observational follow-up study, will be conducted at Year 7 to evaluate long-term effects.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
33995 (estimated)
First submitted
22 Apr 2018
Start date
8 May 2018
Primary completion date
Jan 2026
Lead sponsor
First Hospital of China Medical University
NCT number
NCT03527719

What you commit to

  • Study type: Interventional
  • Planned participants: 33995
  • From 8 May 2018 to the primary completion date, Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Eligibility criteria for study villages:
  • The village has a regular village doctor who is willing to participate in the hypertension control project
  • The village does not plan to merge with other villages within 3 years
  • The village is at least 2 kilometers away from other participating villages
  • The village participates in the China New Rural Cooperative Medical Scheme
    • Eligibility criteria of study participants:
  • Men or women aged ≥40 years
  • Mean untreated systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg or mean treated systolic BP ≥130 mm Hg and/or diastolic BP ≥80 mm Hg for individuals without a history of clinical CVD; or mean treated/untreated systolic BP ≥130 mm Hg and/or diastolic BP ≥80 mm Hg for individuals with a history of clinical coronary heart disease, heart failure, stroke, diabetes, or chronic kidney disease
  • Have lived in a participating village for at least 6 months
  • No intention to migrate within next 3 years
  • Taking part in the New Rural Cooperative Medical Scheme
  • Not pregnant or planning to become pregnant
  • No malignant tumors and life expectancy ≥3 years
  • Willing to participate and able to sign informed consent

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
The First Hospital of China Medical University
Coordinator of this site? Confirm its status		ShenyangChinaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.